Membership Directory
GliaCure, Inc.
Category: Drug Development
Phone: + () 16175320358
Website: http://www.gliacure.com
Location: Boston, MA
Therapeutic Areas: Central nervous system
GliaCure is focused on the development of novel therapies for neurological and neuropsychiatric disorders based on glia targets.
It is known that the brain consists of two types of cells - neurons and glia. Much of the research of the last century has focused on neurons. Founder Philip Haydon’s recent work has identified a novel glia-based target that, in pre-clinical studies, is highly efficacious in reversing Alzheimer’s disease. GliaCure will initially exploit this opportunity to develop novel small molecule pharmaceuticals for the treatment of Alzheimer’s disease, a disorder that, it is estimated, will cost the US $1.1 trillion annually by 2050. GliaCure will also focus on discovering and developing related glia-targeted pharmaceuticals to treat other disorders such as traumatic brain injury, depression, Down Syndrome, Parkinson’s disease, glioblastoma, neuropathic pain, epilepsy, psychiatric and sleep disorders.
